Aridis Pharmaceuticals Inc. (ARDS) earnings
Quarterly and annual ARDS reports and results, each read against the price at its own news timestamp. Back to the ARDS overview →
2 measured ARDS earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Aridis Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +16.39% | |
| Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update | Press release | -6.25% | -16.67% |
Keep exploring
More ARDS: analyst actions → · SEC filings → · ARDS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Medmira Inc (MIR_CDNX) | 31 | 0.00% | 10% |
| BIOFORCE NANOSCIENCES HLD (BFNH) | 30 | +0.30% | 50% |
| Evelo Biosciences, Inc. (EVLO) | 28 | -3.02% | 36% |
| Nu-Med Plus Inc. Com (NUMD) | 28 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.